Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer

NCT01154335 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: OSI-906
DRUG: Everolimus

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]